x
ServiziMenu principaleHome
Facebook Twitter Linkedin Print
Home > News > Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the ph

Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05–2018)

Scarica il documento in PDF

Apri